These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2610927)
41. Synthesis and characterization of a pancreatic trypsin inhibitor homologue and a model inhibitor. Tan NH; Kaiser ET Biochemistry; 1977 Apr; 16(8):1531-41. PubMed ID: 300629 [TBL] [Abstract][Full Text] [Related]
42. Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen. Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M Biochim Biophys Acta; 1985 Dec; 832(3):378-82. PubMed ID: 4074755 [TBL] [Abstract][Full Text] [Related]
43. Transient removal of proflavine inhibition of bovine beta-trypsin by the bovine basic pancreatic trypsin inhibitor (Kunitz). A case for "chronosteric effects". Antonini E; Ascenzi P; Bolognesi M; Menegatti E; Guarneri M J Biol Chem; 1983 Apr; 258(8):4676-8. PubMed ID: 6403532 [TBL] [Abstract][Full Text] [Related]
44. Structural studies of the interactions of normal and abnormal human plasmins with bovine basic pancreatic trypsin inhibitor. Takeda-Shitaka M; Kamiya K; Miyata T; Ohkura N; Madoiwa S; Sakata Y; Umeyama H Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):322-8. PubMed ID: 10212382 [TBL] [Abstract][Full Text] [Related]
45. Trypsin-pancreatic secretory isoinhibitor A from bovine pancreas (Kazal type). Spectroscopic study on structure and stability. Menegatti E; Salvadori S; Guarneri M; Scatturin A Int J Pept Protein Res; 1983 May; 21(5):562-7. PubMed ID: 6885242 [TBL] [Abstract][Full Text] [Related]
46. Isolation and partial characterization of the pancreatic secretory trypsin inhibitor in the rat. Marks WH; Ohlsson K Biochim Biophys Acta; 1982 Jul; 717(1):91-7. PubMed ID: 7104395 [TBL] [Abstract][Full Text] [Related]
47. Structure-activity relationships for the interaction of bovine pancreatic trypsin inhibitor with an intracellular site on a large conductance Ca(2+)-activated K(+) channel. Favre I; Moss GW; Goldenberg DP; Otlewski J; Moczydlowski E Biochemistry; 2000 Feb; 39(8):2001-12. PubMed ID: 10684650 [TBL] [Abstract][Full Text] [Related]
48. [Monoclonal antibodies to the trypsin-binding domain of trypsin inhibitor from human urine]. Ogloblina OG; Bekkert R; Belova LA; Palvanova KD Bioorg Khim; 1994 Mar; 20(3):290-6. PubMed ID: 8166756 [TBL] [Abstract][Full Text] [Related]
50. Comparison of complexes formed by a crustacean and a vertebrate trypsin with bovine pancreatic trypsin inhibitor - the key to achieving extreme stability? Molnár T; Vörös J; Szeder B; Takáts K; Kardos J; Katona G; Gráf L FEBS J; 2013 Nov; 280(22):5750-63. PubMed ID: 24034223 [TBL] [Abstract][Full Text] [Related]
51. Analysis of electrostatic interactions and their relationship to conformation and stability of bovine pancreatic trypsin inhibitor. March KL; Maskalick DG; England RD; Friend SH; Gurd FR Biochemistry; 1982 Oct; 21(21):5241-51. PubMed ID: 7171553 [TBL] [Abstract][Full Text] [Related]
52. Purification and complete amino acid sequence of canine pancreatic secretory trypsin inhibitor. Kikuchi N; Nagata K; Yoshida N; Tanaka T; Yamamoto M; Saitoh Y FEBS Lett; 1985 Oct; 191(2):269-72. PubMed ID: 4054311 [TBL] [Abstract][Full Text] [Related]
53. Miniaturized proteins: the backbone cyclic proteinomimetic approach. Kasher R; Oren DA; Barda Y; Gilon C J Mol Biol; 1999 Sep; 292(2):421-9. PubMed ID: 10493885 [TBL] [Abstract][Full Text] [Related]
54. Varying occurrence of gastroduodenal immunoreactive pancreatic secretory trypsin inhibitor. Bohe M; Lindström CG; Ohlsson K J Clin Pathol; 1987 Nov; 40(11):1345-8. PubMed ID: 3320096 [TBL] [Abstract][Full Text] [Related]
55. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases. Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824 [TBL] [Abstract][Full Text] [Related]
56. On the interaction of bovine pancreatic trypsin inhibitor with maxi Ca(2+)-activated K+ channels. A model system for analysis of peptide-induced subconductance states. Lucchesi KJ; Moczydlowski E J Gen Physiol; 1991 Jun; 97(6):1295-319. PubMed ID: 1714938 [TBL] [Abstract][Full Text] [Related]
57. Selection of potent chymotrypsin and elastase inhibitors from M13 phage library of basic pancreatic trypsin inhibitor (BPTI). Kiczak L; Kasztura M; Koscielska-Kasprzak K; Dadlez M; Otlewski J Biochim Biophys Acta; 2001 Dec; 1550(2):153-63. PubMed ID: 11755204 [TBL] [Abstract][Full Text] [Related]
58. High-performance capillary electrophoresis for the determination of trypsin and chymotrypsin inhibitors and their association with trypsin, chymotrypsin and monoclonal antibodies. Arentoft AM; Frøkiaer H; Michaelsen S; Sørensen H; Sørensen S J Chromatogr A; 1993 Oct; 652(1):189-98. PubMed ID: 8281254 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of the 20S proteosome by a protein proteinase inhibitor: evidence that a natural serine proteinase inhibitor can inhibit a threonine proteinase. Yabe K; Koide T J Biochem; 2009 Feb; 145(2):217-27. PubMed ID: 19054805 [TBL] [Abstract][Full Text] [Related]
60. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. III. Catalytic act of trypsin and its inhibition]. Popov EM; Godzhaev NM; Aliev RE Mol Biol (Mosk); 1986; 20(2):357-68. PubMed ID: 3702867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]